DR. JOEL R SAPER, M.D.
Neurology at Professional Dr, Ann Arbor, MI
License number
Michigan 4301029842
Category
Psychiatric
Type
Pain Medicine
License number
Michigan 4301029842
Category
Neurology
Type
Neurology
Address
Address
3120 Professional Dr, Ann Arbor, MI 48104
Phone
(734) 677-6000
(734) 677-2422 (Fax)
(734) 677-2422 (Fax)
Professional information
Dr. Joel R Saper, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Neurology, Neuropsychiatry (Neurology)
Address:
Michigan Headache and Neurological Institute
3120 Professional Dr, Ann Arbor 48104
(734) 677-6000 (Phone)
3120 Professional Dr, Ann Arbor 48104
(734) 677-6000 (Phone)
Procedures:
Occipital Nerve Blocks, Trigeminal Neuralgia, Trigger Point Injections
Conditions:
Headache
Certifications:
Neurology, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Michigan Headache and Neurological Institute
3120 Professional Dr, Ann Arbor 48104
Chelsea Community Hospital
775 South Main St, Chelsea 48118
3120 Professional Dr, Ann Arbor 48104
Chelsea Community Hospital
775 South Main St, Chelsea 48118
Education:
Medical School
University Of Illinois College Of Medicine Chicago
Graduated: 1969
Michael Reese Hospital and Med Center
Graduated: 1970
University Of Michigan
Graduated: 1973
University Of Illinois College Of Medicine Chicago
Graduated: 1969
Michael Reese Hospital and Med Center
Graduated: 1970
University Of Michigan
Graduated: 1973
Joel Rodney Saper, Ann Arbor MI
Specialties:
Neurology, Pain Medicine
Work:
MHNI - Michigan Head Pain & Neurological Institute
3120 Professional Dr, Ann Arbor, MI 48104
3120 Professional Dr, Ann Arbor, MI 48104
Education:
University of Illinois at Chicago (1969)
Combination Therapy For The Treatment Of Migraine
US Patent:
2002009, Jul 25, 2002
Filed:
Aug 21, 2001
Appl. No.:
09/934276
Inventors:
Joel Saper - Ann Arbor MI, US
International Classification:
A61K031/522
US Classification:
514/263310
Abstract:
A method of treating migraine and compositions useful therein are disclosed. The compositions comprise a selective 5-hydroxytriptamine receptor agonist and acetaminophen, non-steroidal anti-inflammatory agents and/or caffeine.